France: Jeito Capital announces final close of first fund at €534m

Jeito Capital, a Private Equity firm dedicated to biotech and biopharma, has announced the final close of its first fund, Jeito I, at €534m (US$626m), exceeding its original target of €500 million. Jeito I is the largest European fund dedicated to supporting companies in the life sciences sector, according to Jeito founder and CEO, Rafaèle…

You must be a HMI Subscriber to view this content.

Subscribe Now »